|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-4-21
|
|
pubmed:abstractText |
Attenuated, replication-competent herpes simplex viruses (HSVs) have shown promise as antitumor agents for cancer therapy. In this study, we sought to develop a novel type of oncolytic HSV with more potent antitumor activity for use in localized malignant tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0194-5998
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
470-8
|
|
pubmed:dateRevised |
2004-8-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15100647-Animals,
pubmed-meshheading:15100647-Cancer Vaccines,
pubmed-meshheading:15100647-Cell Line, Tumor,
pubmed-meshheading:15100647-Cercopithecus aethiops,
pubmed-meshheading:15100647-Female,
pubmed-meshheading:15100647-Fibrosarcoma,
pubmed-meshheading:15100647-Genetic Engineering,
pubmed-meshheading:15100647-Herpesvirus 1, Human,
pubmed-meshheading:15100647-Immunocompetence,
pubmed-meshheading:15100647-Injections, Intralesional,
pubmed-meshheading:15100647-Mice,
pubmed-meshheading:15100647-Mice, Inbred C3H,
pubmed-meshheading:15100647-Vaccines, Attenuated,
pubmed-meshheading:15100647-Vero Cells,
pubmed-meshheading:15100647-Viral Proteins,
pubmed-meshheading:15100647-Virus Replication,
pubmed-meshheading:15100647-Xenograft Model Antitumor Assays
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses.
|
|
pubmed:affiliation |
Department of Otorhinolaryngology, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
|
|
pubmed:publicationType |
Journal Article
|
